The global poultry probiotic ingredients market is expected to reach USD 984,028.43 thousand by 2030 from USD 614,237.29 thousand in 2022, growing at a CAGR of 6.2% during the forecast period of 2023 to 2030.
Market Segmentation:
Global Poultry Probiotic Ingredients Market, By Product (Bacteria based and Fungi and yeast based), Type (Single Strain and Multiple strain), Form (Dry and Liquid), Function (Feed Intake and Efficiency, Yield, Gut Health, Nutrition, Egg Production & Quality immunity, and Others), Application (Broilers, Layers, Breeders, Chicks & Poults, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Belgium, Denmark, Sweden, Poland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, New Zealand, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Kuwait, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.
Overview of Global Poultry Probiotic Ingredients Market Dynamics:
- Driver
- Increasing awareness of the benefits of plant-based products
- Restraint
- Inadequate raw material availability
- Opportunity
- Growing commercial application of probiotics in poultry products
Market Players:
The key market players operating in the global poultry probiotic ingredients market are listed below:
- Lallemand Inc
- Alltech
- Biocamp
- International Animal Health Products
- Unique Biotech
- Provita Animal Health
- Phileo by Lesaffre
- Novozymes
- Evonik Industries AG
- ASAHI GROUP HOLDINGS, LTD
- Chr. Hansen Holding A/S
- Advanced Enzyme Technologies
- International Flavors & Fragrances Inc
- Kemin Industries, Inc
- PANGOO
TABLE OF CONTENTS
1 INTRODUCTION 43
- 1.1 OBJECTIVES OF THE STUDY 43
- 1.2 MARKET DEFINITION 43
- 1.3 OVERVIEW OF GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET 43
- 1.4 LIMITATIONS 45
- 1.5 MARKETS COVERED 45
2 MARKET SEGMENTATION 48
- 2.1 MARKETS COVERED 48
- 2.2 GEOGRAPHICAL SCOPE 49
- 2.3 YEARS CONSIDERED FOR THE STUDY 50
- 2.4 CURRENCY AND PRICING 50
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
- 2.6 MULTIVARIATE MODELLING 54
- 2.7 PRODUCT LIFELINE CURVE 54
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
- 2.9 DBMR MARKET POSITION GRID 56
- 2.10 MARKET END USERS COVERAGE GRID 57
- 2.11 VENDOR SHARE ANALYSIS 58
- 2.12 SECONDARY SOURCES 59
- 2.13 ASSUMPTIONS 59
3 EXECUTIVE SUMMARY 60
4 PREMIUM INSIGHTS 63
- 4.1 VALUE CHAIN ANALYSIS 65
- 4.2 SUPPLY CHAIN ANALYSIS 66
- 4.2.1 RAW MATERIAL PROCUREMENT 66
- 4.2.2 MANUFACTURING AND DISTRIBUTION 66
- 4.2.3 END USERS 66
- 4.3 PORTER'S FIVE FORCES 67
- 4.3.1 BARGAINING POWER OF SUPPLIERS 67
- 4.3.2 BARGAINING POWER OF BUYERS/CONSUMERS 67
- 4.3.3 THREAT OF NEW ENTRANTS 68
- 4.3.4 THREAT OF SUBSTITUTES PRODUCTS 68
- 4.3.5 INTENSITY OF COMPETITIVE RIVALRY 68
- 4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 69
- 4.5 OVERVIEW OF TECHNOLOGICAL INNOVATIONS 70
- 4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 71
- 4.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS 72
5 PRICING ANALYSIS 73
6 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, REGULATIONS 74
7 MARKET OVERVIEW, GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET 76
- 7.1 DRIVERS 78
- 7.1.1 GROWING PRODUCTION OF FEED ADDITIVES 78
- 7.1.2 INCREASING AWARENESS OF THE BENEFITS OF PLANT-BASED PRODUCTS 78
- 7.1.3 INCREASED DEMAND AND CONSUMPTION OF LIVESTOCK-BASED PRODUCTS 79
- 7.2 RESTRAINTS 79
- 7.2.1 STRICT RESTRICTIONS AND REGULATIONS IMPOSED BY GOVERNMENT 79
- 7.2.2 INADEQUATE RAW MATERIAL AVAILABILITY 80
- 7.3 OPPORTUNITIES 80
- 7.3.1 GROWING COMMERCIAL APPLICATION 80
- 7.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 80
- 7.4 CHALLENGES 81
- 7.4.1 AVAILABILITY OF FEED ADDITIVE SUBSTITUTES 81
- 7.4.2 PRODUCT LABELLING AND TRADE ISSUES 81
8 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY PRODUCT 82
- 8.1 OVERVIEW 83
- 8.1.1 BACTERIA BASED 86
- 8.1.1.1 BACILLUS 87
- 8.1.1.1.1 SUBTILIS 88
- 8.1.1.1.2 LICHENIFORMIS 88
- 8.1.1.1.3 AMYLOLIQUEFACIENS 88
- 8.1.1.1.4 MEGATERIUM 88
- 8.1.1.1.5 MESENTRICUS 88
- 8.1.1.1.6 POLYMYXA 88
- 8.1.1.1.7 TOYONENSIS 88
- 8.1.1.1.8 OTHERS 88
- 8.1.1.2 LACTOBACILLUS 89
- 8.1.1.2.1 ACIDOPHILUS 89
- 8.1.1.2.2 BULGARICUS 89
- 8.1.1.2.3 REUTERI 89
- 8.1.1.2.4 CASEI 90
- 8.1.1.2.5 LACTIS 90
- 8.1.1.2.6 SALIVARIUS 90
- 8.1.1.2.7 PLANTARUM 90
- 8.1.1.2.8 RHAMNOSUS 90
- 8.1.1.2.9 FERMENTUM 90
- 8.1.1.2.10 FARCIMINIS 90
- 8.1.1.2.11 THERMOPHILUS 90
- 8.1.1.2.12 OTHERS 91
- 8.1.1.3 BIFIDOBACTERIUM 91
- 8.1.1.3.1 BIFIDIUM 91
- 8.1.1.3.2 BIFIDUS 91
- 8.1.1.3.3 THERMOPHILUS 91
- 8.1.1.3.4 ANIMALS 91
- 8.1.1.3.5 OTHERS 92
- 8.1.1.4 ENTEROCOCCUS 92
- 8.1.1.5 STREPTOCOCCUS 92
- 8.1.1.6 CLOSTRIDIUM 92
- 8.1.1.7 PEDIOCOCCUS 92
- 8.1.1.7.1 PARVULUS 92
- 8.1.1.7.2 ACIDILACTICI 92
- 8.1.1.7.3 OTHERS 93
- 8.1.2 FUNGI AND YEAST BASED 93
- 8.1.2.1 SACCHAROMYCES CEREVISIAE 94
- 8.1.2.2 SACCHAROMYCES BOULARDII 94
- 8.1.2.3 SACCHAROMYCES SERVISIA 94
- 8.1.2.4 CANDIDA 94
9 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY TYPE 95
- 9.1 OVERVIEW 96
- 9.1.1 SINGLE STRAIN 99
- 9.1.2 MULTIPLE STRAIN 99
10 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY FORM 101
- 10.1 OVERVIEW 102
- 10.1.1 DRY 105
- 10.1.2 LIQUID 105
11 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY FUNCTION 107
- 11.1 OVERVIEW 108
- 11.1.1 GUT HEALTH 111
- 11.1.2 IMMUNITY 111
- 11.1.3 NUTRITION 112
- 11.1.4 FEED INTAKE AND EFFICIENCY 113
- 11.1.5 YIELD 113
- 11.1.6 EGG PRODUCTION AND QUALITY 114
- 11.1.7 OTHERS 115
12 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 116
- 12.1 OVERVIEW 117
- 12.1.1 CHICKS AND POULTS 120
- 12.1.1.1 BACTERIA BASED 121
- 12.1.1.2 FUNGI AND YEAST BASED 121
- 12.1.2 BROILERS 121
- 12.1.2.1 BACTERIA BASED 122
- 12.1.2.2 FUNGI AND YEAST BASED 122
- 12.1.3 LAYERS 122
- 12.1.3.1 BACTERIA BASED 123
- 12.1.3.2 FUNGI AND YEAST BASED 123
- 12.1.4 BREEDERS 123
- 12.1.4.1 BACTERIA BASED 124
- 12.1.4.2 FUNGI AND YEAST BASED 124
- 12.1.5 OTHERS 124
13 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY REGION 125
- 13.1 OVERVIEW 126
- 13.2 ASIA-PACIFIC 131
- 13.2.1 CHINA 140
- 13.2.2 INDIA 144
- 13.2.3 JAPAN 148
- 13.2.4 INDONESIA 152
- 13.2.5 THAILAND 156
- 13.2.6 MALAYSIA 160
- 13.2.7 SOUTH KOREA 164
- 13.2.8 AUSTRALIA 168
- 13.2.9 SINGAPORE 172
- 13.2.10 PHILIPPINES 176
- 13.2.11 NEW ZEALAND 180
- 13.2.12 VIETNAM 184
- 13.2.13 REST OF ASIA-PACIFIC 188
- 13.3 NORTH AMERICA 189
- 13.3.1 U.S. 200
- 13.3.2 MEXICO 206
- 13.3.3 CANADA 212
- 13.4 EUROPE 218
- 13.4.1 GERMANY 227
- 13.4.2 RUSSIA 232
- 13.4.3 TURKEY 236
- 13.4.4 ITALY 240
- 13.4.5 U.K. 244
- 13.4.6 FRANCE 248
- 13.4.7 POLAND 252
- 13.4.8 SPAIN 256
- 13.4.9 SWITZERLAND 260
- 13.4.10 NETHERLANDS 264
- 13.4.11 BELGIUM 268
- 13.4.12 DENMARK 272
- 13.4.13 SWEDEN 276
- 13.4.14 REST OF EUROPE 280
- 13.5 SOUTH AMERICA 281
- 13.5.1 BRAZIL 292
- 13.5.2 ARGENTINA 298
- 13.5.3 REST OF SOUTH AMERICA 304
- 13.6 MIDDLE EAST AND AFRICA 305
- 13.6.1 SOUTH AFRICA 316
- 13.6.2 SAUDI ARABIA 323
- 13.6.3 KUWAIT 330
- 13.6.4 U.A.E. 337
- 13.6.5 REST OF MIDDLE EAST AND AFRICA 343
14 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET: COMPANY LANDSCAPE 344
- 14.1 COMPANY SHARE ANALYSIS: GLOBAL 344
- 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 345
- 14.3 COMPANY SHARE ANALYSIS: EUROPE 346
- 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 347
15 SWOT ANALYSIS 348
16 COMPANY PROFILE 349
- 16.1 LALLEMAND INC 349
- 16.1.1 COMPANY SNAPSHOT 349
- 16.1.2 COMPANY SHARE ANALYSIS 349
- 16.1.3 PRODUCT PORTFOLIO 350
- 16.1.4 RECENT DEVELOPMENT 350
- 16.2 EVONIK INDUSTRIES AG 351
- 16.2.1 COMPANY SNAPSHOT 351
- 16.2.2 REVENUE ANALYSIS 351
- 16.2.3 COMPANY SHARE ANALYSIS 352
- 16.2.4 PRODUCT PORTFOLIO 352
- 16.2.5 RECENT DEVELOPMENT 352
- 16.3 ASAHI GROUP HOLDINGS, LTD 353
- 16.3.1 COMPANY SNAPSHOT 353
- 16.3.2 REVENUE ANALYSIS 353
- 16.3.3 COMPANY SHARE ANALYSIS 354
- 16.3.4 PRODUCT PORTFOLIO 354
- 16.3.5 RECENT DEVELOPMENT 354
- 16.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 355
- 16.4.1 COMPANY SNAPSHOT 355
- 16.4.2 REVENUE ANALYSIS 355
- 16.4.3 COMPANY SHARE ANALYSIS 356
- 16.4.4 PRODUCT PORTFOLIO 356
- 16.4.5 RECENT DEVELOPMENT 356
- 16.5 PHILEO BY LESAFFRE 357
- 16.5.1 COMPANY SNAPSHOT 357
- 16.5.2 COMPANY SHARE ANALYSIS 357
- 16.5.3 PRODUCT PORTFOLIO 358
- 16.5.4 RECENT DEVELOPMENT 358
- 16.6 ADVANCED ENZYME TECHNOLOGIES 359
- 16.6.1 COMPANY SNAPSHOT 359
- 16.6.2 REVENUE ANALYSIS 359
- 16.6.3 PRODUCT PORTFOLIO 360
- 16.6.4 RECENT DEVELOPMENT 360
- 16.7 ALLTECH 361
- 16.7.1 COMPANY SNAPSHOT 361
- 16.7.2 PRODUCT PORTFOLIO 361
- 16.7.3 RECENT DEVELOPMENTS 361
- 16.8 BIOCAMP 362
- 16.8.1 COMPANY SNAPSHOT 362
- 16.8.2 PRODUCT PORTFOLIO 362
- 16.8.3 RECENT DEVELOPMENT 362
- 16.9 CHR. HANSEN HOLDING A/S 363
- 16.9.1 COMPANY SNAPSHOT 363
- 16.9.2 REVENUE ANALYSIS 363
- 16.9.3 PRODUCT PORTFOLIO 364
- 16.9.4 RECENT DEVELOPMENT 364
- 16.10 INTERNATIONAL ANIMAL HEALTH PRODUCTS 365
- 16.10.1 COMPANY SNAPSHOT 365
- 16.10.2 PRODUCT PORTFOLIO 365
- 16.10.3 RECENT DEVELOPMENT 365
- 16.11 KEMIN INDUSTRIES, INC 366
- 16.11.1 COMPANY SNAPSHOT 366
- 16.11.2 PRODUCT PORTFOLIO 366
- 16.11.3 RECENT DEVELOPMENT 366
- 16.12 NOVOZYMES 367
- 16.12.1 COMPANY SNAPSHOT 367
- 16.12.2 REVENUE ANALYSIS 367
- 16.12.3 PRODUCT PORTFOLIO 368
- 16.12.4 RECENT DEVELOPMENT 368
- 16.13 PANGOO 369
- 16.13.1 COMPANY SNAPSHOT 369
- 16.13.2 PRODUCT PORTFOLIO 369
- 16.13.3 RECENT DEVELOPMENT 369
- 16.14 PROVITA ANIMAL HEALTH 370
- 16.14.1 COMPANY SNAPSHOT 370
- 16.14.2 PRODUCT PORTFOLIO 370
- 16.14.3 RECENT DEVELOPMENT 370
- 16.15 UNIQUE BIOTECH 371
- 16.15.1 COMPANY SNAPSHOT 371
- 16.15.2 PRODUCT PORTFOLIO 371
- 16.15.3 RECENT DEVELOPMENT 371
17 QUESTIONNAIRE 372
18 RELATED REPORTS 375